Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 7, 2020; 26(45): 7263-7271
Published online Dec 7, 2020. doi: 10.3748/wjg.v26.i45.7263
Published online Dec 7, 2020. doi: 10.3748/wjg.v26.i45.7263
Figure 4 Clinical course of this case.
A-D: Serum tumor markers were elevated. A CT scan after seven courses of chemotherapy revealed increased liver metastasis. CDDP: Cisplatin; CPT-11: Irinotecan; RAM: Ramucirumab; nab-PTX: Nab-Paclitaxel; NIVO: Nivolumab; SOX: S-1 and oxaliplatin; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9; NSE: Neuron-specific enolase; Pro-GRP: Pro-gastrin-releasing peptide.
- Citation: Ishida N, Miyazu T, Tamura S, Suzuki S, Tani S, Yamade M, Iwaizumi M, Osawa S, Hamaya Y, Shinmura K, Sugimura H, Miura K, Furuta T, Sugimoto K. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report. World J Gastroenterol 2020; 26(45): 7263-7271
- URL: https://www.wjgnet.com/1007-9327/full/v26/i45/7263.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i45.7263